Lyric Bio, Inc. is a biotechnology company specializing in next-generation biomanufacturing for human donor-sourced therapeutics. They are developing proprietary tissue engineering technology to produce human immunoglobulin with a bioreactor that can reduce the need for human donations and increase access to life-saving therapies.